Contribution: Industrial Research Assistance Program – Contributions to Firms
Canadian Bio-Systems Inc.
$207,500.00
Enzymatically Hydrolyzed Yeast Carbohydrates
EF 2016-17 · 2016-08-01
Résumé
Evaluation of using enzymatically hydrolyzed yeast carbohydrates, to both improve growth performance, minimize bacterial shedding (i.e. Salmonella sp ), promote the growth of beneficial bacteria within the gastrointestinal tract (GIT) and replace AGP in both swine and poultry models.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Calgary|Calgary, Alberta, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
100523844
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 243 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 243 jours.
Agreement End Date
2019-03-31
Agreement Number
870245
Agreement Start Date
2016-08-01
Agreement Title
Enzymatically Hydrolyzed Yeast Carbohydrates
Agreement Title (French)
Glucides de levure hydrolysés enzymatiquement
Agreement Type
Contribution
Agreement Value
$207,500.00
Amendment Date
2018-09-05
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Evaluation of using enzymatically hydrolyzed yeast carbohydrates, to both improve growth performance, minimize bacterial shedding (i.e. Salmonella sp ), promote the growth of beneficial bacteria within the gastrointestinal tract (GIT) and replace AGP in both swine and poultry models.
Description (French)
Évaluation de l'utilisation de glucides de levure hydrolysés par voie enzymatique pour améliorer la performance de croissance, minimiser l'excrétion bactérienne (par exemple, Salmonella sp), favoriser la croissance de bactéries bénéfiques dans le tractus gastro-intestinal et remplacer l'antibiotique promoteur de croissance (APC) dans les modèles porcins et avicoles.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Shepard
Federal Riding (French)
Calgary Shepard
Federal Riding Number
48011
NAICS Code
311119
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
100523844
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
Canadian Bio-Systems Inc.
Recipient Postal Code
T2C 0J7
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2018-2019-Q2-870245
